Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in Halozyme Therapeutics Inc
Today
Create an eToro account to buy HALO stock on a secure, user-friendly, multi-asset trading platform.
Buy Halozyme Therapeutics Inc
Buy Halozyme Therapeutics Inc
Halozyme Therapeutics Inc HALO
Buy HALO
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Hold
Price Target
57.67
Based on analysts who covered HALO

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.
Stocks-HALO-Halozyme Therapeutics Inc

Halozyme Therapeutics Inc HALO

$60.41-1.04(-1.69%)(1D)
• Nasdaq • in USD

HALO Stock Price Chart

‎4.33‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Halozyme Therapeutics Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Halozyme Therapeutics Inc share price today is $60.41, reflecting a ‎-1.69‎% change over the last 24 hours and ‎1.53‎% over the past week. The current market capitalization of HALO is 7.57B with an average volume in the last three months of 1.36M. The stock has a P/E ratio of 17.9 and a dividend yield of 0%. With the stock’s beta sitting at 0.79
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$7.57B
Day’s Range
i
Shows the high and low prices of the day.
56.87 - 62.96
52W Range
i
Shows the high and low prices of the last year.
32.72 - 65.41
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
1.36M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
17.9
Revenue
i
The total income generated by this company’s goods and services last year.
$1.02B
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$61.45
EPS
i
A company’s total earnings divided by the number of shares it has issued.
3.43
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.79
What Is Halozyme Therapeutics Inc?
Halozyme Therapeutics, Inc. is an American healthcare company, founded in 1998 and based in San Diego, California. The company operates as a biopharma technology platform company serving clients in the United States, Switzerland, and internationally. The organisation combines technology with established and emerging healthcare treatments, with the goal of developing innovative solutions that impact patient experience and patient outcomes.

Halozyme Therapeutics, Inc. is traded on the NASDAQ GS with the ticker HALO. It has been trading as a public company since 2004. The HALO share price showed a 52-week low of $12.71 and a 52-week high of, $29.77, as of October 2020. Halozyme does not currently pay a dividend to stockholders and has no plans to do so in the foreseeable future.

The company has developed a proprietary enzyme that forms the basis of its patented ENHANZE® drug delivery technology. As of October 2020, the organisation has five products on the market that have received regulatory approvals — either within the United States or across global markets — that utilise the enzyme.

If you are interested in adding a new healthcare stock to your portfolio, you can invest in HALO stock today, or add it to your watchlist to monitor price movements.
Buy HALO

How can I buy Halozyme Therapeutics Inc stocks?

To purchase Halozyme Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Halozyme Therapeutics Inc (HALO) page and place an order to buy Halozyme Therapeutics Inc.
Buy HALO
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Halozyme Therapeutics Inc
Invest in Halozyme Therapeutics Inc
Today
Create an eToro account to buy HALO stock on a secure, user-friendly, multi-asset trading platform.
Buy HALO

FAQ

The current price of HALO is $60.41.
The average price target for Halozyme Therapeutics Inc is $60.41. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Halozyme Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Halozyme Therapeutics Inc is $7.57B
Daily Movers
Explore the biggest stocks movers on the market.
Buy HALO
Scroll to top